Table 1.
Factor | Dialysis group | Control group |
---|---|---|
Demographics | ||
No. of patients | 72 | 72 |
Sex | ||
Male | 58 (80.6) | 24 (33.3) |
Female | 14 (19.4) | 48 (66.7) |
Age (yr) | 46.14 ± 8.89 | 40.35 ± 6.65 |
Clinical characteristics | ||
Body mass index (kg/m2) | 20.87 ± 4.26 | 23.12 ± 3.35 |
Diabetes mellitus | 20 (27.8) | 4 (5.6) |
Hypertension | 48 (66.7) | 2 (2.8) |
Dilated cardiomyopathy | 4 (5.6) | - |
Cerebrovascular accident | 4 (5.6) | - |
Hypothyroidism | 2 (2.8) | - |
HCV infection | 36 (50.0) | - |
Blood pressure (mmHg) | ||
Systolic blood pressure | 145.81 ± 15.10 | 127.56 ± 6.20 |
Diastolic blood pressure | 94.77 ± 10.63 | 79.12 ± 4.21 |
Native kidney disease | ||
Diabetic kidney disease | 18 (25.0) | - |
Chronic glomerulonephritis | 14 (19.4) | - |
Chronic interstitial nephritis | 6 (8.3) | - |
Obstructive uropathy | 5 (6.9) | - |
Hypertensive nephrosclerosis | 3 (4.2) | - |
ADPKD | 2 (2.8) | - |
Unknown | 24 (33.3) | - |
Dialysis access | ||
Arteriovenous fistula | 68 (94.4) | - |
Permanent catheter | 4 (5.6) | - |
Dialysis adequacy (Kt/V) | 1.16 ± 0.17 | - |
Dialysis duration (mo) | 8.65 ± 6.68 | - |
Laboratory parameters | ||
Hemoglobin (g/dL) | 8.07 ± 1.33 | 12.69 ± 1.27 |
White blood cell count (cell/mm3) | 6,944.44 ± 2,770.36 | 8,204.17 ± 1,990.99 |
Neutrophils (%) | 67.85 ± 10.54 | 58.11 ± 9.13 |
Lymphocytes (%) | 22.49 ± 14.16 | 31.49 ± 6.72 |
Neutrophil-to-lymphocyte ratio | 3 (2.09 ± 5.26) | 1.79 (1.38 ± 2.57) |
Creatinine (mg/dL) | 7.15 ± 3.29 | 0.88 ± 0.17 |
Sodium (mEq/L) | 133.50 ± 5.22 | 136.49 ± 4.01 |
Potassium (mEq/L) | 4.49 ± 1.05 | 4.27 ± 0.36 |
Albumin (g/dL) | 3.03 ± 0.70 | 4.05 ± 0.37 |
Antibody titer (U/mL) | ||
Reactive titer, ≥0.8 | 64 (88.9) | 72 (100) |
Nonreactive titer, <0.8 | 8 (11.1) | 0 (0) |
Data are expressed as number only, number (%), mean ± standard deviation, or median (interquartile range).
ADPKD, autosomal dominant polycystic kidney disease; HCV, hepatitis C virus.